dsm-firmenich-Novozymes Alliance launches its new generation phytase, HiPhorius™

HiPhorius™ is a complete phytase solution designed to help poultry producers achieve sustainable and profitable protein production. Its commercial release will improve the market standard for phytase technology and enable access to high potency phytase, giving producers more flexibility in diet optimization.

HiPhorius™ raises the market standard for phytase technology, delivering consistent improvements in animal performance through efficient phosphorous utilization. It is a complete phytase solution for poultry, swine and aquaculture species and designed to help farmers achieve sustainable and profitable animal protein production.

HiPhorius™ enables producers to expect increased efficiency, improved thermostability and access to digital services, giving producers opportunities to reduce feed costs. The superior phytate-degrading properties of HiPhorius™ enable precision nutrition with the use of digestible calcium for optimum broiler performance. Using end-to-end digital services for intelligent phytase nutrition, HiPhorius™ offers more out of less feed.

For decades, animal protein producers have relied on phytases as an alternative to inorganic phosphate for both economic and sustainability reasons. Rock phosphate is a non-renewable resource that needs to be managed efficiently. As prices of this important source of phosphorus have increased over recent years and pressure for more sustainable animal protein production grows, more attention has been given to phytases to deliver greater efficiency. With its enhanced potency, HiPhorius™ fills the gap, allowing a significant reduction of phosphorous in monogastric diets. The addition of HiPhorius™ directly contributes to a significant decrease of phosphorus emissions from poultry, swine and fish farming. This not only optimizes value for the farmer but also reduces the environmental footprint of animal production. All these aspects are reflected in the HiPhorius™ slogan, “Adding a little, wins a lot”.

Christie Chavis, Vice President Performance Solutions + BIOMIN® at dsm-firmenich Animal Nutrition and Health, added: “At dsm-firmenich, we are proud of our Alliance with Novozymes in the feed enzyme space. We are convinced that HiPhorius™ will bring significant benefits to our customers whether they are looking to optimize diets or get more efficiency from their current diets. Depending on farm management, objectives and choice of enzymes, our customers typically see feed cost reduction of 1-4% in broilers, for example. That improvement contributes to farmers’ profitability and improves the sustainability of livestock farming while demonstrating how we fulfill the DSM food system commitments’ aim of double-digit reduction of livestock emissions by 2030”.

Robert Vergo, Global Feed Alliance Director at Novozymes, comments: “The launch of HiPhorius™ continues the Alliance’s momentum of delivering impactful innovation, following the successful launch of our second-generation protease, ProAct 360™, in 2021. Innovation like this is a crucial tool to managing our agricultural practices sustainably. HiPhorius™ fortifies our comprehensive enzyme product range within animal nutrition and health".

Kostas Stamatopoulos, Global Product Manager Phytases at dsm-firmenich Animal Nutrition and Health, said: “We are thrilled to launch a new solution to market that brings profound change to the value chain, as well as our shared planet. This new generation of phytase marks the beginning of a new era for phosphorous utilization.”

In alignment with dsm-firmenich's We Make it Possible strategic initiative, which supports a robust and achievable transformation worldwide in sustainable animal protein production, HiPhorius™ improves the lifetime performance of animals, reducing emissions from livestock and making efficient use of natural resources.

HiPhorius™ is in line with the unveiling of three business lines at dsm-firmenich Animal Nutrition and Health that will deliver unparalleled solutions to make animal farming more sustainable and brings a bright new face to dsm-firmenich Animal Nutrition and Health following the successful acquisition of BIOMIN® in 2020. 

About HiPhorius™

HiPhorius™ is an innovative phytase solution that delivers more consistent improvements in performance, along with higher nutrient matrix values. HiPhorius™ improves the market standard for phytase technology, giving producers more flexibility in diet optimization for poultry, swine and aquaculture species. In alignment with dsm-firmenich’s We Make it Possible promise, HiPhorius™ improves the lifetime performance of animals, reducing emissions from livestock and making efficient use of natural resources.

About dsm-firmenich

Royal dsm-firmenichis a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. dsm-firmenich’s purpose is to create brighter lives for all. dsm-firmenich’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we find biological answers to preserve the planet’s resources and help build better lives. As the world’s largest provider of enzyme and microbial technologies, our bio-innovation enables increased health and nutritional benefits, higher agricultural yields, improved washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Published on

25 January 2022

Tags

  • Press release

Media Contact

Cameron Pope - KWT Global on behalf of DSM ANH

Share

You are being redirected.

We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.